retatrutide and ghk-cu GLP-3 (24mg vials) My Peptide Journey: Retatrutide &

- Submit accurate diagnosis codes (ICD-10) supporting the medical necessity of the drug, corresponding to the patient's condition, such as autoimmune disorders, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohns disease, or ankylosing spondylitis, treated by infliximab-axxq, with proper precautions in cases where it may have adverse outcomes

It is an offence in Victoria to possess or sell peptides without authorisation per s 36B(2) of the Drugs, Poisons and Controlled Substances Act 1981

Such re-formulations may also generate intellectual property

Doctors choose hydroxocobalamin based on the patients needs and how they react to treatment